CEL-SCI Corp. (CVM)
1.38
-0.12
(-8.00%)
USD |
NYAM |
Oct 30, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
CEL-SCI Enterprise Value : 25.64M for Oct. 30, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 25.64M |
| October 29, 2026 | 27.75M |
| October 28, 2026 | 29.51M |
| October 27, 2026 | 28.99M |
| October 26, 2026 | 29.34M |
| October 23, 2026 | 30.22M |
| October 22, 2026 | 29.69M |
| October 21, 2026 | 29.87M |
| October 20, 2026 | 28.63M |
| October 19, 2026 | 30.39M |
| October 16, 2026 | 32.86M |
| October 15, 2026 | 31.98M |
| October 14, 2026 | 31.45M |
| October 13, 2026 | 32.15M |
| October 12, 2026 | 33.56M |
| October 09, 2026 | 35.49M |
| October 08, 2026 | 35.67M |
| October 07, 2026 | 38.84M |
| October 06, 2026 | 49.56M |
| October 05, 2026 | 43.94M |
| October 02, 2026 | 42.00M |
| October 01, 2026 | 38.13M |
| September 30, 2026 | 37.60M |
| September 29, 2026 | 32.86M |
| September 28, 2026 | 31.27M |
| Date | Value |
|---|---|
| September 25, 2026 | 30.74M |
| September 24, 2026 | 31.62M |
| September 23, 2026 | 30.92M |
| September 22, 2026 | 31.27M |
| September 21, 2026 | 30.74M |
| September 18, 2026 | 30.57M |
| September 17, 2026 | 27.58M |
| September 16, 2026 | 27.40M |
| September 15, 2026 | 27.40M |
| September 14, 2026 | 28.11M |
| September 11, 2026 | 27.58M |
| September 10, 2026 | 28.11M |
| September 09, 2026 | 28.46M |
| September 08, 2026 | 30.39M |
| September 04, 2026 | 30.04M |
| September 03, 2026 | 29.69M |
| September 02, 2026 | 30.39M |
| September 01, 2026 | 29.69M |
| August 31, 2026 | 29.87M |
| August 28, 2026 | 28.81M |
| August 27, 2026 | 29.51M |
| August 26, 2026 | 29.69M |
| August 25, 2026 | 27.40M |
| August 24, 2026 | 25.64M |
| August 21, 2026 | 26.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 556.15M |
| Amgen, Inc. | 295.24B |
| Anika Therapeutics, Inc. | 267.21M |
| BioCryst Pharmaceuticals, Inc. | 2.646B |
| Imunon, Inc. | 5.227M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.668M |
| Total Expenses (Quarterly) | 5.668M |
| EPS Diluted (Quarterly) | -0.4678 |
| Earnings Yield | -187.2% |
| Normalized Earnings Yield | -187.25 |